Follow

Submissions from 2025

A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy, Manmeet Ahluwalia

Assessment of outcomes and machine Learning-based models to predict local failure risk following stereotactic radiosurgery for small brain metastases, Sreenija Yarlagadda, Yanjia Zhang, Anshul Saxena, Tugce Kutuk, Ranjini Tolakanahalli, Haley Appel, Roberto Herrera, Matthew Hall, Robert Press, D Jay Wieczorek, Cecilia Lee, Tatiana Bejarano, Michael McDermott, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck, Alessandro Villa

Author Correction: Sex disparities in outcomes among hospitalizations for heart failure, Yanjia Zhang, Muni Rubens, Anshul Saxena, Venkataraghavan Ramamoorthy, Sandra Chaparro, and Javier Jimenez

Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial), Rohan Garje

Back in the RACE: (Re) Defining the Role of Radiation Therapy in Liver and Gallbladder Cancers, Michael Chuong

Beyond Randomized Controlled Trials: Embracing Pragmatism for Evidence-Based Online Adaptive Radiation Therapy, Michael Chuong

Blue Ribbon Committee I Review: Findings and Impact, Michael Zinner

PDF

Blue Ribbon Committee I Review: Findings and Impact, Michael Zinner

Characterization of terminated and withdrawn clinical trials for the treatment and prevention of oral mucositis, Alessandro Villa

Chimeric antigen receptor T-cell therapy and bispecific antibodies in the treatment of lymphoma for human immunodeficiency virus-infected patients: A systematic review, Marco Ruiz Andia

Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer, Reshma Mahtani

Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer, Reshma Mahtani

Clinical Outcomes After Proton Therapy Reirradiation for Recurrent Malignant Glioma: Analysis From the Prospective Proton Collaborative Group Registry, Omer Gal, Rupesh Kotecha, and Robert Press

Clinical outcomes of modified partial cystectomy in muscle-invasive bladder cancer: balancing tumor control and quality of life, Arjun Pon Avudaiappan

Closed Expander Salvage With Dual-port Tissue Expander in Implant-based Breast Reconstruction for High Body Mass Index and Ptotic Patients, Aneeq Chaudhry, Rita Loureiro, Charo Thomas, Harry Salinas, Matthew Treiser, and Miguel Medina

PDF

Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review, Alessandro Villa

Comparative Analysis of Signet Ring and Non-Signet Ring Urachal Adenocarcinomas: A National Cancer Database Study, Deerush Sakthivel, Pushan Prabhakar, Rohan Garje, and Murugesan Manoharan

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry, Nadia Bambace

Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis, Reshma Mahtani

Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma, Minesh Mehta

Contrast-enhancing Lesions Induced by Central Nervous System-directed Intensity Modulated Proton Therapy: Distribution Patterns, Kinetics, Risk Factors, and Outcomes, Omer Gal, Jen Yu, Minesh Mehta, Matthew Hall, Robert Press, Yazmin Odia, Michael McDermott, Zachary Fellows, Andrew Wroe, Alonso Gutierrez, and Rupesh Kotecha

Correction: Gonzalez et al. Principles of Surgical Treatment of Soft Tissue Sarcomas. Cancers 2025, 17, 401, Juan Pretell

Correlation Between Neurocognitive Outcomes and Neuroaxonal Connectome Alterations After Whole Brain Radiotherapy: A Proof-of-Concept Study, Sreenija Yarlagadda, Star Belnap, John Candela, Tugce Kutuk, Thailin Companioni Reyes, Miguel Ramirez Menendez, Matthew Hall, Robert Press, Yazmin Odia, Minesh Mehta, Michael McDermott, and Rupesh Kotecha

Crying and Emotional Distress Among Patients in Oral Medicine: A Common and Challenging Scenario, Alessandro Villa